FDA 483 - Xlear Inc. - March 18, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Xlear Inc. in American Fork, UT, was inspected and cited for nine observations related to its manufacturing and quality control practices. The inspection revealed significant deficiencies across materials sampling, stability testing, laboratory controls, quality unit procedures, record keeping, production phase time limits, and labeling controls. These issues indicate a lack of adherence to good manufacturing practices, potentially impacting drug product quality and purity.
ID · 2c69d6a9-66db-4205-b040-d3048d09d6af